Makers Laboratories

Makers Laboratories ROCE

The Return on Capital Employed (ROCE) of Makers Laboratories (506919.BO) as of Oct 24, 2026 is 9.56 %. In the previous year, Return on Capital Employed (ROCE) was 2.62 % — a change of 265.46% (higher).

ROCE

9.56 %

YoY

265.46%

Last updated:

In 2026, Makers Laboratories's return on capital employed (ROCE) was 9.56 %, a 265.46% increase from the 2.62 % ROCE in the previous year.

The Makers Laboratories ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
6.89 INR
Jan 1, 2020
2.54 INR
Jan 1, 2021
6.80 INR
Jan 1, 2022
27.99 INR
Jan 1, 2023
1.85 INR
Jan 1, 2024
-1.88 INR
Jan 1, 2025
2.62 INR
Jan 1, 2026
9.56 INR
The Makers Laboratories ROCE history
YEARROCEYoY
9.56 %+265.46%
2.62 %-239.10%
-1.88 %-201.52%
1.85 %-93.38%
27.99 %+311.77%
6.80 %+167.59%
2.54 %-63.14%
6.89 %-13.12%
7.93 %-37.30%
12.65 %-2.47%
12.97 %+12.55%
11.52 %+72.70%
6.67 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Makers Laboratories Stock analysis

What does Makers Laboratories do? Makers Laboratories Ltd. generates revenue through the manufacturing and marketing of pharmaceutical products across various therapeutic segments. The company's product portfolio includes formulation brands such as Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range), and Exylin (Amoxycillin range). These brands target general health needs and are distributed through the Inspira retail packs division, which covers categories like acid regulatory, anthelmintics, anti-allergics, and anti-hypertensives. The Experia bulk packs division supplies bulk pharmaceutical products including amoxycillin 250 mg capsules and chloroquine phosphate 250 mg tablets to healthcare providers and pharmacies. The company's primary customers are healthcare providers and pharmacies that purchase its formulation brands and bulk packs for resale or direct patient use. The Inspira retail packs division serves retail consumers seeking over-the-counter medications for common ailments, while the Experia bulk packs division caters to institutional buyers needing bulk quantities for distribution. Makers Laboratories Ltd. focuses on the pharmaceuticals segment, offering products that address diverse health conditions through its established brand portfolio. Revenue streams are derived from both retail and bulk sales, with formulation brands driving consumer-facing sales and bulk packs supporting institutional distribution. The company's product range spans multiple therapeutic areas, ensuring consistent demand across different healthcare segments. By maintaining a diverse portfolio of branded and bulk pharmaceutical products, Makers Laboratories Ltd. effectively targets both end consumers and healthcare institutions within the Indian pharmaceutical market. Makers Laboratories is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Makers Laboratories's Return on Capital Employed (ROCE)

Makers Laboratories's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Makers Laboratories's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Makers Laboratories's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Makers Laboratories’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Makers Laboratories stock

Return on Capital Employed (ROCE) of Makers Laboratories is 9.56 % in 2026.

Return on Capital Employed (ROCE) of Makers Laboratories changed from 2.62 % to 9.56 %, representing a 265.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Makers Laboratories since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Makers Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Makers Laboratories

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Makers Laboratories